|
|
|||||||
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
01-20-2017, 08:11 PM
|
|||
|
|||
BRIEF-Additional data analyses from phase IIb trial of MIN-101 in schizophrenia under
BRIEF-Additional data analyses from phase IIb trial of MIN-101 in schizophrenia underscore benefit in multiple measurements of cognitive function
* Additional data analyses from phase IIb trial of MIN-101 in schizophrenia underscore benefit in multiple measurements of cognitive function Source text for Eikon: Further company coverage: ??????? ??????: BRIEF-Additional data analyses from phase IIb trial of MIN-101 in schizophrenia under || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري